| FAQ/Help |
| Calendar |
| Search |
| Today's Posts |
12-24-2009, 01:19 PM
|
#1 | |||
|
||||
|
Senior Member
|
http://www.pharmalot.com/2009/12/fda...28Pharmalot%29
FDA Wants More Byetta Studies: Analyst 1 Comment By Ed Silverman // December 24th, 2009 // 8:10 am The (FDA)agency wants Amylin Pharmaceuticals to run more studies of its Type 2 diabetes drug, which was approved two months ago as a stand-alone treatment, due to safety concerns over pancreatitis... ... You may recall the twice-daily injectable drug was linked to six deaths last year (see here), which hurt sales. However, the Amylin statement didn’t mention additional studies... the (FDA)agency considers post-marketing reports of acute pancreatitis, acute renal failure and thyroid neoplasm to be new safety info. Amylin and Lilly, its Byetta marketing partner, issued a statement saying most of the studies are already under way and have not shown any increased risk of acute pancreatitis... Older discussion about byetta and PD: http://neurotalk.psychcentral.com/sh...ghlight=byetta http://neurotalk.psychcentral.com/sh...ghlight=byetta
__________________
In the last analysis, we see only what we are ready to see, what we have been taught to see. We eliminate and ignore everything that is not a part of our prejudices. ~ Jean-Martin Charcot The future is already here — it's just not very evenly distributed. William Gibson |
|||
|
 Reply With Quote
|
| Reply |
|
|
Similar Threads
|
||||
| Thread | Forum | |||
| Byetta, Exendin, E-4? | Parkinson's Disease | |||
| FDA Alert Exenatide (marketed as Byetta) | Medications & Treatments | |||
| FDA Alert Exenatide (marketed as Byetta) | Diabetes / Insulin Resistance / Metabolic Syndrome | |||
| NEED HELP in finding report of study using byetta in Parkinson's mice | Parkinson's Disease | |||
anyone know of further studies of byetta and PD?
Linear Mode
